Tirzepatide is an innovative medication formulated by medical professionals for the treatment of type-2 diabetes and related obesity. It has attracted much interest due to its dual-action mechanism targeting GLP-1 and GIP receptors. It is essential to study the form of the medication being administered to you. So, what is the debate on Tirzepatide tablets vs. injections? SlimNow MD presents justified facts on Tirzepatide tablets vs. injections so that you can discuss the best suited route of administration with your healthcare provider.
Methods of Tirzepatide Administration: Injectables or Tablets
Once a week, injectable Tirzepatide is given subcutaneously to maintain a steady effect on your body. This route does not involve the digestive system. Therefore, the results are more predictable. Also, the subcutaneous route increases the bioavailability of Tirzepatide.
Oral tirzepatide is taken once a day. It is primarily accessible through compounded forms. This oral route is convenient if you do not favor needles. However, the effectiveness of Tirzepatide may be impacted by the involvement of the digestive tract.
Clinical Results and Effectiveness
Injectable Tirzepatide has been shown in clinical trials to produce better glycemic control and weight loss outcomes. For example, individuals using 15 mg of Tirzepatide once a week lost an average of 11.2 kg of weight, which was better than other therapies. On the other hand, the efficacy of oral Tirzepatide is doubtful. It is difficult to determine the effectiveness of compounded oral formulations because they have not undergone detailed clinical studies. Concerns over potential adverse effects are also raised by the requirement for bigger dosages to produce equivalent benefits.
Side Effects and Safety
Either oral or subcutaneous route, Tirzepatide may cause the following adverse indications:
- Constipation
- Diarrhea
- Vomiting
- Nausea
Nonetheless, the safety profile of injectable Tirzepatide has been well studied in clinical studies. Due to a lack of evidence, the safety of oral compounded forms is unknown.
Availability and Regulatory Status
The FDA has only approved injectable Tirzepatide formulations so far. Oral Tirzepatide products have not received FDA approval because compounded oral versions are unregulated. Also, their efficacy and quality might vary.
Cost Factors
The cost of injectable Tirzepatide can be high, more than $1,000 per month. The compounded oral versions could be less expensive. However, the savings might not be justified due to their unregulated status and questionable effectiveness.
Tirzepatide Tablets vs. Injections: Make the Correct Decision
Consider the following factors while deciding between tirzepatide injections and tablets:
Efficacy
The efficacy of injections is scientifically proven and approved by the FDA.
Convenience
Tablets are simple to use. However, daily dosage may be necessary.
Safety
While oral versions lack thorough evidence, injections have proven safety profiles.
Regulatory Approval
The FDA has only approved injectable Tirzepatide.
Cost
Although tablets could be less expensive, their worth is debatable without demonstrated effectiveness.
The Bottom Line
Hence, to choose the best option between Tirzepatide tablets vs. injections, weigh the pros and cons of both routes of administration. Speak with your healthcare professional to make the right, healthful decision. Book an appointment for an individualized consultation session on Tirzepatide treatment.